Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CDT Environmental Technology Investment Holdings | CDTG | Aug 30, 2024 | 3.40 | +1.49 |
CDW | CDW | Aug 30, 2024 | 225.64 | +1.13 |
CEA Industries | CEAD | Aug 30, 2024 | 6.94 | 0.00 |
CECO Environmental | CECO | Aug 30, 2024 | 28.95 | +2.15 |
Cedar Realty Trust B Pref | CDR-B | Aug 30, 2024 | 14.54 | +1.11 |
Cedar Realty Trust C Pref | CDR-C | Aug 30, 2024 | 13.51 | +4.97 |
CEF Income Composite Powershares | PCEF | Aug 30, 2024 | 19.29 | +0.38 |
Cel-Sci | CVM | Aug 30, 2024 | 1.08 | -0.46 |
Celanese | CE | Aug 30, 2024 | 130.60 | +0.42 |
Celcuity | CELC | Aug 30, 2024 | 15.96 | -0.93 |
Celestica | CLS | Aug 30, 2024 | 50.92 | +0.69 |
Celldex Therapeutics | CLDX | Aug 30, 2024 | 41.33 | +3.51 |
Cellebrite | CLBT | Aug 30, 2024 | 17.06 | +0.59 |
Cellectar Biosciences | CLRB | Aug 30, 2024 | 2.20 | +0.46 |
Cellectis ADR | CLLS | Aug 30, 2024 | 2.40 | 0.00 |
Celsius | CELH | Aug 30, 2024 | 38.03 | +1.06 |
Celularity A | CELU | Aug 30, 2024 | 3.08 | +3.08 |
Cementos Pacasmayo ADR | CPAC | Aug 30, 2024 | 5.55 | -2.72 |
CEMEX ADR | CX | Aug 30, 2024 | 6.13 | +1.32 |
Cemtrex | CETX | Aug 30, 2024 | 0.15 | +0.61 |
Cencora | COR | Aug 30, 2024 | 239.57 | +0.83 |
Cenntro | CENN | Aug 30, 2024 | 1.32 | 0.00 |
Cenovus Energy | CVE | Aug 30, 2024 | 18.54 | -2.16 |
Centene | CNC | Aug 30, 2024 | 78.83 | +0.69 |
CenterPoint Energy | CNP | Aug 30, 2024 | 27.30 | +0.81 |
Centerra Gold | CGAU | Aug 30, 2024 | 7.08 | -0.98 |
Centerspace | CSR-C | Aug 30, 2024 | 24.65 | -0.10 |
Centessa Pharmaceuticals ADR | CNTA | Aug 30, 2024 | 13.50 | +3.53 |
Centogene N.V | CNTG | Aug 30, 2024 | 0.35 | 0.00 |
Centrais Electricas Brasileiras B ADR | EBR-B | Aug 30, 2024 | 8.27 | +2.10 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.